Target
Cytochrome P450 1A2
Ligand
BDBM50246967
Substrate
n/a
Meas. Tech.
ChEMBL_1677274 (CHEMBL4027417)
IC50
>30000±n/a nM
Citation
 Kung, PPBingham, PBrooun, ACollins, MDeng, YLDinh, DFan, CGajiwala, KSGrantner, RGukasyan, HJHu, WHuang, BKania, RKephart, SEKrivacic, CKumpf, RAKhamphavong, PKraus, MLiu, WMaegley, KANguyen, LRen, SRichter, DRollins, RASach, NSharma, SSherrill, JSpangler, JStewart, AESutton, SUryu, SVerhelle, DWang, HWang, SWythes, MXin, SYamazaki, SZhu, HZhu, JZehnder, LEdwards, M Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquin J Med Chem 61:650-665 (2018) [PubMed]  Article 
Target
Name:
Cytochrome P450 1A2
Synonyms:
CP1A2_HUMAN | CYP1A2 | CYPIA2 | Cholesterol 25-hydroxylase | Cytochrome P(3)450 | Cytochrome P450 1A | Cytochrome P450 1A2 (CYP1A2) | Cytochrome P450 4 | Cytochrome P450-P3
Type:
Enzyme
Mol. Mass.:
58423.38
Organism:
Homo sapiens (Human)
Description:
P05177
Residue:
516
Sequence:
MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPLLGHVLTLGKNPHLALSRMSQRYGDVLQIRIGSTPVLVLSRLDTIRQALVRQGDDFKGRPDLYTSTLITDGQSLTFSTDSGPVWAARRRLAQNALNTFSIASDPASSSSCYLEEHVSKEAKALISRLQELMAGPGHFDPYNQVVVSVANVIGAMCFGQHFPESSDEMLSLVKNTHEFVETASSGNPLDFFPILRYLPNPALQRFKAFNQRFLWFLQKTVQEHYQDFDKNSVRDITGALFKHSKKGPRASGNLIPQEKIVNLVNDIFGAGFDTVTTAISWSLMYLVTKPEIQRKIQKELDTVIGRERRPRLSDRPQLPYLEAFILETFRHSSFLPFTIPHSTTRDTTLNGFYIPKKCCVFVNQWQVNHDPELWEDPSEFRPERFLTADGTAINKPLSEKMMLFGMGKRRCIGEVLAKWEIFLFLAILLQQLEFSVPPGVKVDLTPIYGLTMKHARCEHVQARLRFSIN
  
Inhibitor
Name:
BDBM50246967
Synonyms:
CHEMBL4080228 | US10570121, Example 81
Type:
Small organic molecule
Emp. Form.:
C22H24Cl2N2O5
Mol. Mass.:
467.342
SMILES:
CO[C@H](C1COC1)c1cc(Cl)c2CCN(Cc3c(OC)cc(C)[nH]c3=O)C(=O)c2c1Cl |r|
Structure:
Search PDB for entries with ligand similarity: